Xebio Co., Ltd. announced consolidated and non-consolidated earnings results for the third quarter of fiscal 2016. For the period, on consolidated basis, the company reported net sales of JPY 167,015 million against JPY 157,620 million a year ago. Operating profit was JPY 5,958 million against JPY 5,190 million a year ago. Ordinary profit was JPY 6,144 million against JPY 5,597 million a year ago. Net profit was JPY 3,358 million against JPY 3,051 million a year ago. Capital expenditure was JPY 5,296 million.

For the period, on non-consolidated basis, the company reported net sales of JPY 231,203 million against JPY 210,672 million a year ago. Operating profit was JPY 9,437 million against JPY 5,654 million a year ago. Ordinary profit was JPY 9,729 million against JPY 6,432 million a year ago. Net profit was JPY 4,360 million against JPY 2,084 million a year ago.

For the year, on consolidated basis, the company expects net sales of JPY 173,839 million, operating profit of JPY 7,179 million, ordinary profit of JPY 7,406 million and net profit of JPY 4,265 million.